Literature DB >> 11235050

Robert Koch and the pressures of scientific research: tuberculosis and tuberculin.

C Gradmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11235050      PMCID： PMC1044696          DOI： 10.1017/s0025727300000028

Source DB:  PubMed          Journal:  Med Hist        ISSN： 0025-7273            Impact factor:   1.419


× No keyword cloud information.
  18 in total

1.  New images of a new medicine: visual evidence for the widespread popularity of therapeutic discoveries in America after 1885.

Authors:  B Hansen
Journal:  Bull Hist Med       Date:  1999       Impact factor: 1.314

2.  [Not Available].

Authors:  C Gradmann
Journal:  Med Ges Gesch       Date:  1995

3.  Invisible enemies: bacteriology and the language of politics in imperial Germany.

Authors:  C Gradmann
Journal:  Sci Context       Date:  2000       Impact factor: 0.425

4.  Science as receptor of technology: Paul Ehrlich and the synthetic dyestuffs industry.

Authors:  A S Travis
Journal:  Sci Context       Date:  1989       Impact factor: 0.425

5.  Medical and biological constraints: early research on variation in bacteriology.

Authors:  O Amsterdamska
Journal:  Soc Stud Sci       Date:  1987-11       Impact factor: 3.885

6.  [A centenary which has not kept all its promises: tuberculin].

Authors:  M Chauvet
Journal:  Rev Med Suisse Romande       Date:  1990-12

7.  [The history of tuberculin therapy--its discovery by Robert Koch, its forerunners and further development].

Authors:  J M Schmidt
Journal:  Pneumologie       Date:  1991-10

8.  Introduction to special issue on rethinking the reception of the germ theory of disease: comparative perspectives.

Authors:  N J Tomes; J H Warner
Journal:  J Hist Med Allied Sci       Date:  1997-01       Impact factor: 2.088

9.  [The so-called Koch postulates].

Authors:  A Grafe
Journal:  Gesnerus       Date:  1988

10.  Bacteriological and physiological research styles in the early controversy on the nature of the bacteriophage phenomenon.

Authors:  T van Helvoort
Journal:  Med Hist       Date:  1992-07       Impact factor: 1.419
View more
  7 in total

1.  Before there were standards: the role of test animals in the production of empirical generality in physiology.

Authors:  Cheryl A Logan
Journal:  J Hist Biol       Date:  2002       Impact factor: 1.326

2.  The Legacy of Robert Koch: Surmise, search, substantiate.

Authors:  Ritu Lakhtakia
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

Review 3.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

Review 4.  The impact of COVID-19 on tuberculosis: challenges and opportunities.

Authors:  Surya Kant; Richa Tyagi
Journal:  Ther Adv Infect Dis       Date:  2021-06-09

Review 5.  The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus.

Authors:  I Barberis; N L Bragazzi; L Galluzzo; M Martini
Journal:  J Prev Med Hyg       Date:  2017-03

Review 6.  Tuberculosis: a timeless challenge for medicine.

Authors:  E Armocida; M Martini
Journal:  J Prev Med Hyg       Date:  2020-07-04

7.  In Silico Characterization and Virtual Screening of GntR/HutC Family Transcriptional Regulator MoyR: A Potential Monooxygenase Regulator in Mycobacterium tuberculosis.

Authors:  Thanusha Dhananji Abeywickrama; Inoka Chinthana Perera
Journal:  Biology (Basel)       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.